Results 141 to 150 of about 269,130 (350)

Scintigraphy with 99mTc(V)-DMSA in monitoring patients with inflammatory bowel disease [PDF]

, 2013
The clinical significance of pentavalent technetium-99m dimercaptosuccinic acid (99mTc(V)-DMSA) scintigraphy in diagnosing inflammatory bowel disease (IBD) has not yet been fully elucidated. The aim of this prospective paper was to study the above.
Abedi, J., Amiriani, T., Assadi, M., Besharat, S., Javadi, H., Mirkarimi, H.S., Semnani, S., Seyedabadi, M.   +7 more
core  

Antioxidant and Anti-Inflammatory Properties of a Thuja occidentalis Mother Tincture for the Treatment of Ulcerative Colitis [PDF]

, 2019
Miruna S. Stan, Sorina Nicoleta Voicu, Sonia Caruntu, Ionela Cristina Nica, Neli-Kinga Oláh, Ramona Flavia Burtescu, Cornel Baltă, Marcel Roșu, Hildegard Herman, Anca Hermenean, Anca Dinischiotu   +10 more
openalex   +1 more source

Eudragit®‐engineered pH‐responsive probiotic microspheres with enhanced gastrointestinal resistance and prolonged storage stability for inflammatory bowel disease therapy

BMEMat, EarlyView.
This study reports the development of AMS@Eud core‐shell microspheres, combining calcium alginate and pH‐responsive Eudragit® L100, which exhibit exceptional gastrointestinal resistance and long‐term storage stability (only 5.28%–9.09% viability loss over 35 days at 4–25°C), and effectively alleviate inflammatory bowel disease via gut microbiota ...
Ming Teng, Xiaomin Luo, Peng Zhang, Chen Yang, Yuniel Ma, Xinhua Liu   +5 more
wiley   +1 more source

The Stressor Factors and Perceived Social Support in the Patients with Ulcerative Colitis

مجله دانشکده پزشکی اصفهان, 2011
• Background: Ulcerative colitis (UC) is an inflammatory bowel disease (IBD) characterized with chronic inflammation of mucosal surface of bowels. Genetic, immunologic, environmental and individual factors contribute disease have been identified in ...
Hamid Afshar, Hamed Daghaghzadeh, Ali Toghiani, Peyman Adibi, Reza Bagherian   +4 more
doaj  

Ulcerative colitis: let's talk about extent [PDF]

, 2016
Ulcerative colitis (UC) is a chronic inflammatory disease in which clinical course varies substantially between patients. The extent of the disease is usually pointed out as one of the factors responsible for this variation.
Antunes, A., Belo, T., Caldeira, Paulo, Eusébio, Marta, Gago, T., Guerreiro, H., Queiros, P., Vaz, A.   +7 more
core  

Isoform Specificity of a Compound Targeting Actin Filaments Containing Tropomyosin Tpm1.8/1.9

Cytoskeleton, EarlyView.
ABSTRACT The unbranched actin filaments in mammalian cells are usually composed of co‐polymers of a specific tropomyosin isoform with actin. Genetic manipulation has revealed that the tropomyosins largely define the functional properties of actin filaments in an isoform‐specific, non‐redundant manner.
Jeff Hook, Edna C. Hardeman, Peter W. Gunning   +2 more
wiley   +1 more source

Survey of demographic characteristics and diagnostic features of Ulcerative colitis patients in Ardabil province [PDF]

Introduction :Ulcerative colitis is an inflammatory disease of gastrointestinal tract. Although, determination of epidemiological characteristics and risk factors and clinical features and treatment, can lead to management of this disease, we therefore ...
ادیبان, وحید, اعظمی, احد, یزدانبد, عباس   +2 more
core  

A randomised phase I study of etrolizumab (rhuMAb β7) in moderate to severe ulcerative colitis. [PDF]

, 2013
ObjectiveEtrolizumab (rhuMAb β7, anti-β7, PRO145223) is a humanised monoclonal antibody targeting the β7 subunit of the heterodimeric integrins α4β7 and αEβ7, which are implicated in leucocyte migration and retention in ulcerative colitis (UC).
Baumgart, Daniel C, Bressler, Brian, Danilenko, Dimitri, Egen, Jackson, Fedorak, Richard N, Hommes, Daan W, Keir, Mary, Luca, Diana, Mansfield, John C, O'Byrne, Sharon, Rutgeerts, Paul J, Schreiber, Stefan, Sturm, Andreas, Tang, Meina, Visich, Jennifer, Wei, Xiaohui, Williams, Marna   +16 more
core  

Measuring the Impact of the Substitution of Innovator Biologics With Biosimilars on Uptake and Costs Among Ontario Public Drug Benefit Recipients

Clinical Pharmacology &Therapeutics, EarlyView.
In Ontario, biologics have historically represented a small proportion of public drug claims but a large proportion of spending. Biosimilars, lower cost alternatives to biologics, offer a potential solution to the rising spending on biologics. From March 2023 to January 2024, the Ontario Ministry of Health required public drug program beneficiaries on ...
Anita Iacono, Martin K. H. Ho, Joanna Yang, Tonya Campbell, William Wynne, Dana Shearer, Lene Andersen, Eric Majer, Shaleesa Ledlie, Mina Tadrous, Tara Gomes   +10 more
wiley   +1 more source

HLA TYPING OF ULCERATIVE COLITIS IN IRAN

Acta Medica Iranica, 1996
Ulcerative colitis is an acute or chronic inflammatory bowel disease that diffusely involves the colonic mucosa. the etiology of ulcerative colitis is unknown.
Froutan, H., Nikbin, B. Habibabadi, M.   +4 more
doaj